Interleukin-27 and Autoimmune Disorders: A Comprehensive Review of Immunological Functions
Author Information
Author(s): Yazdanpanah Esmaeil, Pazoki Alireza, Dadfar Sepehr, Nemati Mohammad Hosein, Sajad Siadati Seyed Mohammad, Tarahomi Mahdieh, Orooji Niloufar, Haghmorad Dariush, Oksenych Valentyn
Primary Institution: Semnan University of Medical Sciences
Conclusion
Interleukin-27 plays complex roles in autoimmune disorders, acting as both a mediator and inhibitor of inflammation, with potential therapeutic implications.
Supporting Evidence
- IL-27 is involved in the regulation of immune responses in various autoimmune diseases.
- Research indicates that IL-27 can both promote and inhibit inflammation depending on the context.
- IL-27 levels are altered in patients with autoimmune disorders, suggesting its role in disease pathogenesis.
- Further studies are needed to explore IL-27 as a potential therapeutic target in autoimmune diseases.
Takeaway
Interleukin-27 is a special protein that helps control the immune system, and it can both help and hurt people with autoimmune diseases, where the body attacks itself.
Methodology
This is a review article summarizing existing research on the role of interleukin-27 in various autoimmune disorders.
Limitations
The review highlights the need for further research to fully understand IL-27's mechanisms and therapeutic potential.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website